MTEX
Mannatech, Incorporated NASDAQ Listed Feb 16, 1999$7.60
Mkt Cap $14.7M
52w Low $3.80
43.9% of range
52w High $12.45
50d MA $6.47
200d MA $6.31
P/E (TTM)
—
EV/EBITDA
1.8x
P/B
—
Debt/Equity
-1.4x
ROE
291.3%
P/FCF
-3.3x
RSI (14)
45.20
ATR (14)
$0.70
Beta
0.82
50d MA
$6.47
200d MA
$6.31
Avg Volume
40.7K
Mannatech, Incorporated operates as a health and wellness company worldwide. It develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management products. The company primarily sells its products directly, as well as through e-commerce and network marketing channels. Mannatech, Incorporated was founded in 1993 and is headquartered in Flower Mound, Texas.
1410 Lakeside Parkway · Flower Mound, TX 75028 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 15, 2026 | AMC | — | -5.94 | — | 4.96 | +3.6% | +6.9% | -1.9% | -3.5% | -3.2% | -3.3% | — |
| Nov 12, 2025 | AMC | — | 1.01 | — | 9.51 | +0.0% | +0.1% | +0.7% | -0.8% | -1.8% | +1.3% | — |
| Aug 12, 2025 | AMC | — | -2.27 | — | 8.71 | -2.4% | +14.7% | -0.9% | -8.1% | -6.0% | -1.4% | — |
| May 13, 2025 | AMC | — | -0.80 | — | 11.79 | +0.0% | +0.0% | -7.6% | -3.1% | -14.6% | +0.0% | — |
| Mar 26, 2025 | AMC | — | 1.20 | — | 9.00 | +3.7% | +1.6% | -3.4% | +4.0% | -5.1% | -3.3% | — |
| Nov 12, 2024 | AMC | — | -0.17 | — | 7.50 | +0.1% | +6.7% | -6.1% | +12.4% | -3.7% | -1.0% | — |
| Aug 13, 2024 | AMC | — | -0.33 | — | 7.20 | +0.0% | -1.9% | +2.8% | +3.0% | -4.4% | -0.4% | — |
| May 14, 2024 | AMC | — | 0.63 | — | 7.40 | +10.1% | +7.4% | -3.6% | +0.0% | +0.0% | +0.0% | — |
| Mar 28, 2024 | AMC | — | -0.94 | — | — | — | — | — | — | — | — | — |
| Nov 7, 2023 | AMC | — | 0.01 | — | 8.78 | +0.0% | +0.0% | +0.0% | -3.3% | +0.0% | -0.4% | — |
| Aug 14, 2023 | AMC | — | -0.59 | — | 14.23 | -8.9% | -6.3% | +0.2% | +1.0% | -5.0% | -6.1% | — |
| May 12, 2023 | AMC | — | 0.32 | — | 12.50 | +3.0% | +1.6% | +0.8% | -2.3% | +0.7% | +3.5% | — |
No analyst ratings available.
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| May 20, 2026 | JOBE LARRY ADir | — | Buy | 2,803 | $4.12 | $12K | 70,000 | -1.13% | -0.18% |
| May 19, 2026 | Robbins Kevin AndrewDir | — | Buy | 7,100 | $4.17 | $30K | 33,333 | +11.90% | +6.13% |
| May 19, 2026 | JOBE LARRY ADir | — | Buy | 5,000 | $4.20 | $21K | 67,197 | +11.90% | +6.13% |
8-K · 5.02
!!! Very High
Mannatech, Incorporated -- 8-K 5.02: Executive Change
Sep 1
8-K · 5.02
!!! Very High
Mannatech, Incorporated -- 8-K 5.02: Executive Change
Jun 8
8-K
Mannatech, Incorporated -- 8-K Filing
Jun 3
8-K
Mannatech Inc. -- 8-K Filing
Mannatech (MTEX) has 45 days to submit a Nasdaq compliance plan or faces delisting, with a potential 180-day extension if the plan is accepted by October 2026.
Apr 24
8-K
Unknown — 8-K Filing
MTEX's 8.2% Q4 revenue decline to $26.6 million signals weakening demand momentum, which could pressure earnings and warrant caution for investors concerned about sustained growth prospects.
Apr 15
NT 10-K
!!! Very High
Unknown — Late Annual Report — Distress Signal
Mannatech's late annual report filing signals potential financial or operational distress, which could trigger regulatory penalties, exchange delisting risk, and investor confidence loss if underlying issues aren't quickly resolved.
Apr 2
8-K · 8.01
!! High
Unknown — 8-K 8.01: Material Event / Announcement
Mannatech disclosed a late filing notification, signaling potential regulatory compliance issues or operational delays that could concern investors about management effectiveness and trigger NASDAQ listing requirement scrutiny.
Apr 2
NT 10-K
!!! Very High
Unknown — Late Annual Report — Distress Signal
Mannatech's late annual report filing signals potential financial or operational distress, risking delisting and eroding investor confidence in management's ability to maintain compliance and transparency.
Apr 1
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
MTEX experienced an executive change that could signal strategic shifts or instability; investors should monitor whether leadership changes improve operational execution or indicate internal governance concerns.
Mar 24
Institutional (13F) — Top 12
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Blackrock, Inc. | 52,163 | $272K | New | Jun 2026 |
| 2 | Vanguard Capital Management Llc | 41,528 | $216K | Reduced | Jun 2026 |
| 3 | Renaissance Technologies Llc | 30,078 | $157K | Reduced | Jun 2026 |
| 4 | Ifg Advisory, Llc | 19,090 | $99K | New | Jun 2026 |
| 5 | Acadian Asset Management Llc | 7,741 | $46K | — | Mar 2026 |
| 6 | Ubs Group Ag | 485 | $3K | Added | Mar 2026 |
| 7 | Arax Advisory Partners | 12 | $63 | — | Jun 2026 |
| 8 | Morgan Stanley | 2 | $32 | Reduced | Dec 2025 |
| 9 | Sbi Securities Co., Ltd. | 1 | $5 | New | Jun 2026 |
| 10 | Citigroup Inc | 1 | $5 | — | Jun 2026 |
| 11 | Wells Fargo & Company/mn | 1 | $4 | New | Mar 2026 |
| 12 | Royal Bank Of Canada | 80 | — | Added | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 13
All ↗
| # | Fund | Shares | Value | Period |
|---|---|---|---|---|
| 1 | Ultra-Small Company Fund | 23,388 | $140K | Mar 2026 |
| 2 | Fidelity Extended Market Index Fund | 6,376 | $44K | Feb 2026 |
| 3 | EA Bridgeway Omni Small-Cap Value ETF | 5,566 | $33K | Mar 2026 |
| 4 | Dimensional U.S. Targeted Value ETF | 2,523 | $19K | Jan 2026 |
| 5 | Fidelity Nasdaq Composite Index Fund | 1,393 | $10K | Feb 2026 |
| 6 | Fidelity Series Total Market Index Fund | 1,681 | $10K | May 2026 |
| 7 | Dimensional US Core Equity 1 ETF | 1,200 | $9K | Jan 2026 |
| 8 | U.S. Targeted Value Portfolio | 1,106 | $8K | Jan 2026 |
| 9 | U.S. CORE EQUITY 2 PORTFOLIO | 867 | $7K | Jan 2026 |
| 10 | U.S. Sustainability Core 1 Portfolio | 805 | $6K | Jan 2026 |
| 11 | Dimensional US Sustainability Core 1 ETF | 350 | $3K | Jan 2026 |
| 12 | Fidelity Total Market Index Fund | 422 | $2K | May 2026 |
| 13 | U.S. CORE EQUITY 1 PORTFOLIO | 293 | $2K | Jan 2026 |
Valuation
Market Cap
$14.7M
Enterprise Value
$11.0M
P/E (TTM)
—
Forward P/E
—
PEG Ratio
0.00x
P/B
—
P/S
0.14x
P/FCF
-3.35x
EV/EBITDA
1.75x
Shares Out
1.9M
Financials (TTM)
Revenue
$107.4M
Net Income
-$7.4M
EBITDA
$6.3M
Free Cash Flow
-$4.3M
Op Cash Flow
-$3.0M
EPS Basic
$-8.00
EPS Diluted
$-3.91
EPS Forward
—
Gross Margin
76.1%
Op Margin
2.5%
Net Margin
-6.9%
Balance Sheet
Total Assets
$30.0M
Total Liab.
$35.2M
Total Equity
-$5.2M
Cash
$6.2M
LT Debt
$2.8M
Book Value/Sh
$-2.75
Debt/Equity
-1.41x
Current Ratio
1.10
Quick Ratio
0.56
Returns & Growth
ROE
291.3%
ROA
-50.7%
ROIC
10.5%
Rev Growth YoY
-8.3%
EPS Growth YoY
-706.1%
Price Returns
2W
-7.3%
1M
+12.8%
3M
+45.9%
6M
+11.8%
12M
-23.6%
Technicals
52W High
$12.45
52W Low
$3.80
50d MA
$6.47
200d MA
$6.31
RSI (14)
45.20
ATR (14)
$0.70
Beta
0.82
Avg Volume
41K
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
4
Ex-Div Date
Jun 14, 2023
Analyst Price Targets
Consensus
—
High
—
Low
—
Median
—
Data updated apr 26, 2026 1:40pm
· Source: financialmodelingprep.com